| Original language | English (US) |
|---|---|
| Pages (from-to) | e1-e3 |
| Journal | Diabetes care |
| Volume | 41 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1 2018 |
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Advanced and Specialized Nursing
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Monocyte DPP4 expression in human atherosclerosis is associated with obesity and dyslipidemia. / Rao, Xiaoquan; Deiuliis, Jeffrey A.; Mihai, Georgeta; Varghese, Juliet; Xia, Chang; Frieman, Matthew B.; Sztalryd, Carole; Sun, Xiao Jian; Quon, Michael J.; Taylor, Simeon I.; Ajagopalan, Sanjay; Zhong, Jixin.
In: Diabetes care, Vol. 41, No. 1, 01.01.2018, p. e1-e3.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Monocyte DPP4 expression in human atherosclerosis is associated with obesity and dyslipidemia
AU - Rao, Xiaoquan
AU - Deiuliis, Jeffrey A.
AU - Mihai, Georgeta
AU - Varghese, Juliet
AU - Xia, Chang
AU - Frieman, Matthew B.
AU - Sztalryd, Carole
AU - Sun, Xiao Jian
AU - Quon, Michael J.
AU - Taylor, Simeon I.
AU - Ajagopalan, Sanjay
AU - Zhong, Jixin
N1 - Funding Information: Acknowledgments. The authors thank clinical staff (Lisa Hafer at The Ohio State University, Kylene Broadwater and Steven Sawicki at the University of Maryland School of Medicine) for their help with subject recruitment and sample collection. Funding. This work was supported by grants from the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases(K01DK105108),AmericanHeartAssociation (17GRNT33670485), American Association of Immunologists (CIIF-8745), and National Natural Science Foundation of China (81670431). X.R. was supported by grants from the National Institute of Environmental Health Sciences (K99ES026241) and the National Institute of Diabetes and Digestive and Kidney Diseases (T32DK098107). Duality of Interest. S.I.T. was previously employed by Bristol-Myers Squibb and currently owns stock in that company. S.R. has served as a consultant for Takeda Pharmaceuticals and Boehringer Ingelheim. J.Z. has received funding support from Boehringer Ingelheim (IIS2015-10485). No other potential conflicts of interest relevant to this article were reported. Author Contributions. X.R., C.X., and J.Z. researched data. G.M. and J.V. were responsible for MRI measurement of aortic plaque. X.R. and J.Z. wrote the manuscript. S.R. and J.Z. reviewed and edited the manuscript. J.A.D. and C.S. contributed to clinical tissue collection. M.B.F., X.J.S.,M.J.Q.,andS.I.T.contributedtodiscussion of experimental design. J.Z. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
PY - 2018/1/1
Y1 - 2018/1/1
UR - http://www.scopus.com/inward/record.url?scp=85038954287&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85038954287&partnerID=8YFLogxK
U2 - 10.2337/dc17-0672
DO - 10.2337/dc17-0672
M3 - Article
C2 - 29127241
AN - SCOPUS:85038954287
VL - 41
SP - e1-e3
JO - Diabetes Care
JF - Diabetes Care
SN - 1935-5548
IS - 1
ER -